Pharma
New Vaccine for TB Developed
A team of Dutch scientists at the Statens Serum Institute in Copenhagen, an effective vaccine to fight tuberculosis (TB) before and after infection has developed.
Tysabri for the Treatment of Multiple Sclerosis
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.
Effort To Curb Illicit Rx Drug Activity Online
Google and Microsoft have partnered with the US administration to establish a not-for-profit organisation aimed at blocking illegal online pharmacies from selling counterfeit prescription drugs.
Tuberculosis Drug Improves Social Skills
The scientists from Eastern Virginia Medical School have identified a potential novel treatment strategy for the social impairment of people with Autism Spectrum Disorders (ASD).
European Pharmacists call for pharmacist access To electronic patient records
The Pharmaceuctical Group of the European Union (PGEU) the association representing Community Pharmacists, calls for pharmacists to be granted access to electronic patient records in a statement on E Health released.
Pune vaccine to help Africa combat meningitis menace
An indigenous vaccine will help rid Africa of meningitis, one of the continent’s worst enemies.
Sale of obesity drug banned in India
The sale of anti-obesity medicine Sibutramine has been banned in India due to rising instances of heart attacks among its users, the Drugs Controller General of India (DCGI) revealed.
Global polio eradication initiative may save US $40-50 billion
The global initiative to eradicate polio could provide net benefits of at least US $40-50 billion if transmission of wild polioviruses is interrupted within the next five years, according to a new study.
Sun Pharma receives USFDA nod for generic Clarinex, Tiazac
The Mumbai-based firm has received approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) to market a generic version of Schering Plough’s Clarinex tablets, Sun Pharma said in a statement.
DCGI drafts rules on third-generation antibiotics
Even as the health ministry drags its feet over a national antibiotic policy, the Central Drugs Standard Control Organisation has prepared draft notifications that will regulate antibiotic drugs and the treatment of infectious diseases.
Lupin gets FDA nod for anti-allergic tablets
Drug firm Lupin announced it has been granted final approval by the United states Food and Drug Administration (USFDA) for antihistamine Desloratadine tablets, used for treating allergies.
Dr Reddy
Dr Reddy
